Bewell Pharmaceuticals Pvt Ltd

Bewell Pharmaceuticals Pvt Ltd - pharma in Kolkata, West Bengal, India. FY 2026 financials & compliance.
CIN U27201WB1987PTC042976 Incorporated 08 September 1987 ROC Kolkata HQ Kolkata, West Bengal, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2025
₹7,217
Latest filing
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹9.6 Lakh
Issued & subscribed
Satisfied charges
₹16.79 Cr
No open charges
Company age
39 yrs
Est. 1987
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
Last financials
Mar 2025
Balance sheet date

About Bewell Pharmaceuticals Pvt Ltd

Data last updated:

Bewell Pharmaceuticals Pvt Ltd is a private limited company based in Kolkata, West Bengal, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 08 September 1987 and has been in existence for over 39 years.

The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U27201WB1987PTC042976. Its GSTIN is 19AABCB1894P1Z2 (West Bengal).

The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹9.6 Lakh. It is led by directors Krishna Kumar Sadani (Whole-Time Director) and Sushil Kumar Sadani.

Its last annual general meeting (AGM) was held on 29 November 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at P – 599 Keyatala Road, Kolkata, West Bengal, India – 700029.

As per MCA filings, the company has satisfied charges of ₹16.79 Cr on record. Court records list 8 cases involving the company, including 7 filed against it; 7 cases are pending.

The current compliance status is marked as compliant by the Registrar of Companies.

Company Details of Bewell Pharmaceuticals Pvt Ltd
CIN U27201WB1987PTC042976
Registration Number 042976
Incorporation Date 08 September 1987
ROC Kolkata
Listing Status Unlisted
Company Status Active
Date of Last AGM 29 November 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    Locked
  • Social Media
    Locked
  • Registered Address
    P – 599 Keyatala Road, Kolkata, West Bengal, India – 700029
  • Industry
    Pharma, Drug Formulation & Development
Comprehensive company report
Bewell Pharmaceuticals Pvt Ltd - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
  • One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Unlock the full Bewell Pharmaceuticals Pvt Ltd report

Financials, compliance, directors, charges, ownership and filings for Bewell Pharmaceuticals Pvt Ltd in one report.

Financials from 2015 Directors & ownership Charges & compliance

Business Activity of Bewell Pharmaceuticals Pvt Ltd

The main business activity of Bewell Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main Activity Group CodeDescription of Main ActivityBusiness Activity CodeDescription of Business ActivityTurnover Percentage
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical productsLocked
Premium access

Business activity turnover details

Turnover share and past changes in activity are in the company report.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Financials of Bewell Pharmaceuticals Pvt Ltd FY 2025 filings available

Bewell Pharmaceuticals Pvt Ltd reported revenue of ₹7,217 for FY 2025.

Revenue · FY 2025
₹7,217

Compounded Annual Growth Rate (CAGR) of Bewell Pharmaceuticals Pvt Ltd

Revenue CAGR growth
5 years · compounded
▼ 74%

Revenue has declined at a compounded annual rate (CAGR) of 74% over five years. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary of Bewell Pharmaceuticals Pvt Ltd

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations••••••••••••••••••••
Other Income••••••••••••••••••••
Total Revenue••••••••••••••••••••
Cost of Materials Consumed••••••••••••••••••••
Employee Benefit Expense••••••••••••••••••••
Finance Costs••••••••••••••••••••
Depreciation and Amortisation••••••••••••••••••••
Other Expenses••••••••••••••••••••
Total Expenses••••••••••••••••••••
EBITDA••••••••••••••••••••
Profit Before Tax••••••••••••••••••••
Tax Expense••••••••••••••••••••
Net Profit (PAT)••••••••••••••••••••
Balance Sheet
Share Capital••••••••••••••••••••
Reserves and Surplus••••••••••••••••••••
Net Worth (Total Equity)••••••••••••••••••••
Long-term Borrowings••••••••••••••••••••
Short-term Borrowings••••••••••••••••••••
Trade Payables••••••••••••••••••••
Total Liabilities••••••••••••••••••••
Fixed Assets••••••••••••••••••••
Investments••••••••••••••••••••
Inventories••••••••••••••••••••
Trade Receivables••••••••••••••••••••
Cash and Bank Balance••••••••••••••••••••
Total Assets••••••••••••••••••••

Financial Ratios of Bewell Pharmaceuticals Pvt Ltd

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin••••••••••••••••••••
Net Profit Margin••••••••••••••••••••
Return on Equity (ROE)••••••••••••••••••••
Return on Capital Employed (ROCE)••••••••••••••••••••
Return on Assets (ROA)••••••••••••••••••••
Liquidity and Debt
Current Ratio••••••••••••••••••••
Quick Ratio••••••••••••••••••••
Debt-to-Equity Ratio••••••••••••••••••••
Interest Coverage Ratio••••••••••••••••••••
Efficiency and Growth
Asset Turnover••••••••••••••••••••
Receivable Days••••••••••••••••••••
Payable Days••••••••••••••••••••
Inventory Days••••••••••••••••••••
Revenue Growth••••••••••••••••••••
Net Profit Growth••••••••••••••••••••

Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Bewell Pharmaceuticals are in the company report.

Premium access

Financial statements from 2015

Earlier years and trend charts are in the company report.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Board of Directors of Bewell Pharmaceuticals Pvt Ltd

Bewell Pharmaceuticals has 2 current directors and 10 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Krishna Kumar SadaniWhole-Time Director01 Sep 201511 Years 1 MonthsCurrent
Sushil Kumar SadaniDirector15 Jan 20260 Years 9 MonthsCurrent

Peer Comparison of Bewell Pharmaceuticals Pvt Ltd

Bewell Pharmaceuticals Pvt Ltd is compared with the companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Medluck Pharmaceutical Private Limited₹7,500 (FY 2025)••••••••-98.0%••••Aurangabad, Maharashtra, India
Loban Pharmaceuticals Private Limited₹7,500 (FY 2025)••••••••-98.0%••••Zirakpur, Punjab, India
Heartkort Pharmaceuticals Private Limited₹7,498 (FY 2024)••••••••••••Gokalgarh, Haryana, India
Alrioz Pharmaceuticals Private Limited₹7,398 (FY 2025)••••••••-90.0%••••Kolkata, West Bengal, India
Walter Bushnell Pharmaceuticals Private Limited₹7,280 (FY 2024)••••••••-4.0%••••Mohali, Punjab, India
Bewell Pharmaceuticals Pvt Ltd this company₹7,217 (FY 2025)••••••••••••Kolkata, West Bengal, India
Ambesten Pharmaceuticals Private Limited₹7,196 (FY 2025)••••••••-100.0%••••Hyderabad, Telangana, India
Suman and Sons Pharmaceuticals Private Limited₹7,170 (FY 2024)••••••••-99.0%••••Gaya, Bihar, India
Panvila Pharmaceuticals Private Limited₹7,135 (FY 2025)••••••••-97.0%••••Thane, Maharashtra, India
Orange Pharma Private Limited₹7,100 (FY 2025)••••••••16.0%••••Delhi, India
Graceherbal Private Limited₹7,000 (FY 2025)••••••••75.0%••••Pune, Maharashtra, India

Peers are the five companies nearest above and the five nearest below Bewell Pharmaceuticals by revenue in the Pharma industry (Formulations, Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.

Auditor Details of Bewell Pharmaceuticals Pvt Ltd

Bewell Pharmaceuticals Pvt Ltd is audited by ASPA & Co for the financial year 2023.

NameStatusAppointment DateCessation Date
ASPA & CoLockedLockedLocked
Premium access

Complete auditor history

Appointment and cessation dates and past auditor changes are in the company report.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Ownership and Shareholding of Bewell Pharmaceuticals Pvt Ltd

Premium access

Shareholding and ownership data

Promoter, institutional, public and beneficial ownership figures are in the company report.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Bewell Pharmaceuticals Pvt Ltd

Open charges
None
Satisfied charges
₹16.79 Cr
Breakdown by lending institutions
State Bank of India₹13.45 Cr
Allahabad Bank₹3.34 Cr
Latest charge details
DateLenderAmountStatus
03 Jun 2011State Bank of India₹12.45 CrSatisfied
13 Oct 2010Allahabad Bank₹3.34 CrSatisfied
16 Jun 2005State Bank of India₹99.96 LakhSatisfied

Total charge records: 3 View all charges

Employees and EPFO Compliance at Bewell Pharmaceuticals Pvt Ltd

Employment history and EPFO contributions of people linked to Bewell Pharmaceuticals.

Premium access

Employee and EPFO history

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

Recent Activity on Bewell Pharmaceuticals Pvt Ltd

Bewell Pharmaceuticals Pvt Ltd has 12 board changes on record since 2010: 2 appointments and 10 cessations. The latest: Sushil Kumar Sadani was appointed as Director on 15 Jan 2026.

Appointed
Sushil Kumar Sadani was appointed as Director.
Ceased
Krishna Kumar Sadani ceased to be Additional Director.
AGM
Bewell Pharmaceuticals Pvt Ltd last Annual general meeting of members was held on 29 Nov 2025 as per latest MCA records.
Filing
Bewell Pharmaceuticals Pvt Ltd has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Kolkata.
Charges
A charge registered on 03 Jun 2011 via Charge ID 10290507 with State Bank Of India was fully satisfied on 20 Sep 2024.
Ceased
Sushil Kumar Sadani ceased to be Director.
Ceased
Sangeeta Sadani ceased to be Additional Director.
Ceased
Bulbul Chatterjee ceased to be Additional Director.
Ceased
Samir Chatterjee ceased to be Director.
Ceased
Sunirmoy Mondal ceased to be Director.
Appointed
Krishna Kumar Sadani was appointed as Whole-Time Director.
Ceased
Santu Malakar ceased to be Director.

11 earlier events are listed in the company report.

Credit Ratings, Litigation & Regulatory Alerts for Bewell Pharmaceuticals Pvt Ltd

Premium access

Credit ratings, litigation, and regulatory alerts

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Bewell Pharmaceuticals Pvt Ltd

Premium access

MSME payment history

Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Bewell Pharmaceuticals Pvt Ltd

Premium access

Corporate group structure

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

GST Compliance of Bewell Pharmaceuticals Pvt Ltd

Bewell Pharmaceuticals has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
19AABCB1894P1Z2West BengalActive17 Dec 2024
Premium access

GST registrations and filing compliance

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Bewell Pharmaceuticals Pvt Ltd

Premium access

MCA filings and documents

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Bewell Pharmaceuticals Pvt Ltd

Bewell Pharmaceuticals is an active private limited company based in Kolkata, West Bengal, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 08 September 1987 (39+ years old) and is registered under CIN U27201WB1987PTC042976.

Bewell Pharmaceuticals has 2 current directors:

The GSTIN of Bewell Pharmaceuticals is 19AABCB1894P1Z2, registered in West Bengal.

The CIN (Corporate Identification Number) of Bewell Pharmaceuticals is U27201WB1987PTC042976. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Bewell Pharmaceuticals has 8 court cases on record: 7 filed against it. 7 are pending.

Bewell Pharmaceuticals was incorporated on 08 September 1987, making it 39+ years old. It is registered with the Registrar of Companies, Kolkata.

The peers of Bewell Pharmaceuticals by revenue are Medluck Pharmaceutical Private Limited, Loban Pharmaceuticals Private Limited, Heartkort Pharmaceuticals Private Limited, Alrioz Pharmaceuticals Private Limited, Walter Bushnell Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Formulations, Pharmaceuticals).

Sushil Kumar Sadani was appointed as Director on 15 Jan 2026. Krishna Kumar Sadani ceased to be Additional Director on 14 Jan 2026. Sushil Kumar Sadani ceased to be Director on 04 Feb 2019. Bewell Pharmaceuticals has 12 board changes on record in total.

The registered office of Bewell Pharmaceuticals is at P – 599 Keyatala Road, Kolkata, West Bengal, India – 700029.

Bewell Pharmaceuticals has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹9.6 Lakh.

Bewell Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available